Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Administration & dosage (1)
- Adult (1)
- Aged (1)
- Agonists (1)
- Animals (1)
-
- Autoantibodies (1)
- Autoantigens (1)
- Biomarkers (1)
- Biosynthesis (1)
- Cattle (1)
- Cell line (1)
- Chondrocytes (1)
- Drug combinations (1)
- Drug effects (1)
- Enzymologic (1)
- Enzymology (1)
- Female (1)
- Fluorescent antibody technique (1)
- Gene expression regulation (1)
- Genetics (1)
- HeLa cells (1)
- Indirect (1)
- Male (1)
- Matrix Metalloproteinase Inhibitors (1)
- Matrix Metalloproteinases (1)
- Metabolism (1)
- Middle aged (1)
- Organic Chemicals (1)
- PPAR gamma (1)
Articles 1 - 2 of 2
Full-Text Articles in Rheumatology
Stress Granules And Rna Processing Bodies Are Novel Autoantibody Targets In Systemic Sclerosis, Michael E. Johnson, Andrew V. Grassetti, Jaclyn N. Taroni, Shawn M. Lyons, Devin Schweppe, Jessica K. Gordon, Robert F. Speira, Robert Lafyatis, Paul J. Anderson, Scott A. Gerber, Michael L. Whitfield
Stress Granules And Rna Processing Bodies Are Novel Autoantibody Targets In Systemic Sclerosis, Michael E. Johnson, Andrew V. Grassetti, Jaclyn N. Taroni, Shawn M. Lyons, Devin Schweppe, Jessica K. Gordon, Robert F. Speira, Robert Lafyatis, Paul J. Anderson, Scott A. Gerber, Michael L. Whitfield
Dartmouth Scholarship
Autoantibody profiles represent important patient stratification markers in systemic sclerosis (SSc). Here, we performed serum-immunoprecipitations with patient antibodies followed by mass spectrometry (LC-MS/MS) to obtain an unbiased view of all possible autoantibody targets and their associated molecular complexes recognized by SSc.
Retinoid X Receptor And Peroxisome Proliferator-Activated Receptor-Gamma Agonists Cooperate To Inhibit Matrix Metalloproteinase Gene Expression, Peter S. Burrage, Adam C. Schmucker, Yanqing Ren, Michael B. Sporn, Constance E. Brinckerhoff
Retinoid X Receptor And Peroxisome Proliferator-Activated Receptor-Gamma Agonists Cooperate To Inhibit Matrix Metalloproteinase Gene Expression, Peter S. Burrage, Adam C. Schmucker, Yanqing Ren, Michael B. Sporn, Constance E. Brinckerhoff
Dartmouth Scholarship
We recently described the ability of retinoid X receptor (RXR) ligand LG100268 (LG268) to inhibit interleukin-1-beta (IL-1-β)-driven matrix metalloproteinase-1 (MMP-1) and MMP-13 gene expression in SW-1353 chondrosarcoma cells. Other investigators have demonstrated similar effects in chondrocytes treated with rosiglitazone, a ligand for peroxisome proliferator-activated receptor-gamma (PPARγ), for which RXR is an obligate dimerization partner. The goals of this study were to evaluate the inhibition of IL-1--induced expression of MMP-1andMMP-13 by combinatorial treatment with RXR and PPAR ligands and to investigate the molecular mechanisms of this inhibition.